The Committee discussed and made recommendations on the clinical development plan for Pfizer’s investigational Staphylococcus aureus vaccine intended for pre-surgical prophylaxis in elective orthopedic surgical populations.
Back to All Events
Earlier Event: November 1
Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee
Later Event: November 8
Advisory Committee on Heritable Disorders in Newborns and Children